81 related articles for article (PubMed ID: 21898490)
1. Apoptosis: a barrier against cancer no more?
Baumgartner F; Villunger A
Hepatology; 2011 Oct; 54(4):1121-4. PubMed ID: 21898490
[No Abstract] [Full Text] [Related]
2. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice.
Qiu W; Wang X; Leibowitz B; Yang W; Zhang L; Yu J
Hepatology; 2011 Oct; 54(4):1249-58. PubMed ID: 21725994
[TBL] [Abstract][Full Text] [Related]
3. p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice.
Chen S; Zheng J; Hao Q; Yang S; Wang J; Chen H; Chen L; Zhou Y; Yu C; Jiao B; Cai Z
J Hepatol; 2010 Jun; 52(6):864-71. PubMed ID: 20413175
[TBL] [Abstract][Full Text] [Related]
4. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
5. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
[TBL] [Abstract][Full Text] [Related]
6. Much ado about Nutlin.
Teoh NC
J Gastroenterol Hepatol; 2011 Feb; 26(2):213-5. PubMed ID: 21261708
[No Abstract] [Full Text] [Related]
7. Identification of proteins that regulate radiation-induced apoptosis in murine tumors with wild type p53.
Seong J; Oh HJ; Kim J; An JH; Kim W
J Radiat Res; 2007 Sep; 48(5):435-41. PubMed ID: 17721044
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation index and the expression of p53 and Bcl-2 in tumorous and non-tumorous lesions of hepatocellular carcinoma and metastatic liver cancer.
Yoon DS; Cheong JH; Park YN; Kwon SW; Chi HS; Kim BR
Yonsei Med J; 1998 Oct; 39(5):424-9. PubMed ID: 9821791
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
10. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
[TBL] [Abstract][Full Text] [Related]
12. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.
Liu K; Lin D; Ouyang Y; Pang L; Guo X; Wang S; Zang Y; Chen D
Tumour Biol; 2017 Mar; 39(3):1010428317695026. PubMed ID: 28351301
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
Cheng Q; Cao X; Yuan F; Li G; Tong T
Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
[TBL] [Abstract][Full Text] [Related]
15. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
17. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
18. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic p53 is not required for PUMA-induced apoptosis.
Callus BA; Ekert PG; Heraud JE; Jabbour AM; Kotevski A; Vince JE; Silke J; Vaux DL
Cell Death Differ; 2008 Jan; 15(1):213-5; author reply 215-6. PubMed ID: 17992194
[No Abstract] [Full Text] [Related]
20. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]